HomeAnticoagulants General ClassAnticoagulants General Class + Netupitant And Palonosetron

Does Anticoagulants General Class Interact with Netupitant And Palonosetron?

Anticoagulants General Class and Netupitant And Palonosetron have a moderate drug interaction according to U.S. FDA drug labeling data. Netupitant inhibits CYP3A4 for 6 days, increasing plasma concentrations of CYP3A4 substrates. Avoid concomitant use for one week if feasible; if unavoidable, consider dose reduction. The mechanism involves cyp3a4 inhibition by netupitant. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Moderate
Netupitant And Palonosetron Class
Serotonin-3 Receptor Antagonist
Management
Monitor for effects
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Anticoagulants General Class and Netupitant And Palonosetron occurs because cyp3a4 inhibition by netupitant. Clinically, this means netupitant inhibits cyp3a4 for 6 days, increasing plasma concentrations of cyp3a4 substrates. avoid concomitant use for one week if feasible; if unavoidable, consider dose reduction. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.

What To Tell Your Doctor or Pharmacist

If you are taking Anticoagulants General Class and your doctor is considering prescribing Netupitant And Palonosetron (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Anticoagulants General Class+💊 Netupitant And Palonosetron(Akynzeo)

Severity & Interaction Details

🟡
moderate
Be aware — moderate interaction
Documented interaction with manageable risk. May require dose adjustment or monitoring.
Severity scale
MinorContra
On record
Yes
Drug A class
Drug B class
Serotonin-3 Receptor Antagonist
Source
NLP:netupitant and palonosetron

What this means in plain English

Netupitant inhibits CYP3A4 for 6 days, increasing plasma concentrations of CYP3A4 substrates. Avoid concomitant use for one week if feasible; if unavoidable, consider dose reduction.

What the FDA label says

"CYP3A4 inhibition by netupitant"

📖 Source: NLP:netupitant and palonosetron

Share this result:XFacebookWhatsAppReddit
Add more drugs
Check Anticoagulants General Class and Netupitant And Palonosetron against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.